Regen BioPharma Inc (RGBP)

[Natureboy1]

Retail doesn’t short penny plays. The Market Makers do and they do it all the time especially if the company is engaged with toxic financing. No exception here. Yes, Koos has a spotty track record, but where this one differs is the patents and the fact that they are smack dab in the middle of a new and burgeoning mRNA industry. Anybody that wants to use NR2F6 must go through Regen, regardless of whether you think he is a charlatan or not. As others have posted here, this is undeniable.